ArticleiScience2023

Neoadjuvant chemotherapy enhances anti-tumor immune response of tumor microenvironment in human esophageal squamous cell carcinoma.

Sho Okuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.